Jiangsu Hengrui Medicine Co. Ltd. In-Licenses China Rights to AMD mAb From X-BODY BioSciences, Inc.
4/5/2013 11:56:18 AM
More...
|
X-BODY Biosciences Announces Multi-Million Dollar Development Alliance With Jiangsu Hengrui Medicine Co. Ltd., a Leading Pharmaceutical Company in China, to Develop Novel Therapeutic Antibodies for AMD
4/4/2013 9:50:53 AM
More...
|
ShangPharma Achieves First Milestone in Jiangsu Hengrui Medicine Co. Ltd. Biologics Partnership
1/19/2012 12:25:27 PM
More...
|
Jiangsu Hengrui Medicine Co. Ltd. and Crown Bioscience, Inc. Announce Antibody Partnership
1/13/2012 2:55:00 PM
More...
|
Jiangsu Hengrui Medicine Co. Ltd. Gains FDA Approval for Cancer Drug
12/20/2011 12:38:38 PM
More...
|
ShangPharma Subsidiary and Jiangsu Hengrui Medicine Co. Ltd. Partner in Therapeutic Antibody Research and Development
9/15/2011 10:01:06 AM
More...
|
Jiangsu Hengrui Medicine Co. Ltd. to Put New Diabetes Drug in US Trials
8/25/2009 1:57:53 PM
More...
|